DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 63 filers reported holding DERMA SCIENCES INC in Q3 2016. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $59,000 | -3.3% | 11,320 | -13.7% | 0.01% | -28.6% |
Q3 2016 | $61,000 | -44.0% | 13,120 | -52.5% | 0.01% | -48.1% |
Q2 2016 | $109,000 | -28.3% | 27,620 | -43.7% | 0.03% | -44.9% |
Q1 2016 | $152,000 | +16.0% | 49,035 | +71.5% | 0.05% | -38.0% |
Q4 2015 | $131,000 | – | 28,600 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |